- Raised $8M funding round, Nov 2021
- Raised $6M funding round, Jun 2020
About
Curesponse’s technology represents the next step in personalized cancer medicine, advancing prediction capabilities beyond genomics to understand how cancer treatments will affect the patient’s tumor cells when they are in their native tumor.
The company developed cResponse, a test combined Genomic-Functional assay. The test starts with genomic profiling of the tumor to prioritize potential therapies. Then, together with additional therapies that were recommended by the patient’s oncologist, a short list of drugs and drug combinations is generated and functionally tested on the patient’s tumor.
The cResponse functional test preserves the original tumor composition (commonly referred to as the Tumor MicroEnvironment – TME) and its 3D structure to assess the effectiveness of all selected treatments on the tumor cells. This enables cResponse to empirically analyze the effectiveness of the recommended treatments following rapid genomic profiling with very high accuracy.
Funding history · 2 rounds · $14.0M total
Q&A
- What is Curesponse's primary focus?
- Curesponse specializes in personalized medicine for accurate cancer treatment, utilizing a technology that predicts how cancer treatments will affect a patient's tumor cells in their native environment.
- What is the name of Curesponse's core technology?
- Curesponse developed cResponse, a combined Genomic-Functional assay that tests the effectiveness of selected treatments on a patient's tumor while preserving its original composition and 3D structure.
- When was Curesponse founded?
- Curesponse was founded in November 2017.
- How many employees does Curesponse have?
- Curesponse has 11-50 employees.
- What is Curesponse's total funding to date?
- Curesponse has raised a total of $14,000,000 USD.
- When was Curesponse's most recent funding round and how much was raised?
- Curesponse's most recent funding round was in November 2021, raising $8,000,000 USD.
- Which investors participated in Curesponse's June 2020 funding round?
- In June 2020, Curesponse received funding from aMoon Fund and NCL Technology Ventures.
- Who are the co-founders of Curesponse?
- The co-founders of Curesponse are Guy Neev, who serves as CEO, and Seth Salpeter, who is the CTO.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | curesponse.com/ |
|---|---|
| linkedin.com/company/18434992 | |
| facebook.com/Curesponse | |
| YouTube | youtube.com/@curesponse/featured |
Identifiers & details
| Founded | 2017-11 |
|---|---|
| Employees (exact) | 18 |
| Offices | United Kingdom |
Radar intelligence
Patents
| EPO | 1 |
|---|
Publications (Crossref)
| Works | 4 |
|---|
Web history (Wayback)
| Domain | curesponse.com |
|---|
Certificate / subdomain footprint
| Subdomains | 4 |
|---|